174 related articles for article (PubMed ID: 31129098)
1. Ca
Sharma S; Wu SY; Jimenez H; Xing F; Zhu D; Liu Y; Wu K; Tyagi A; Zhao D; Lo HW; Metheny-Barlow L; Sun P; Bourland JD; Chan MD; Thomas A; Barbault A; D'Agostino RB; Whitlow CT; Kirchner V; Blackman C; Pasche B; Watabe K
EBioMedicine; 2019 Jun; 44():194-208. PubMed ID: 31129098
[TBL] [Abstract][Full Text] [Related]
2. Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca
Jimenez H; Wang M; Zimmerman JW; Pennison MJ; Sharma S; Surratt T; Xu ZX; Brezovich I; Absher D; Myers RM; DeYoung B; Caudell DL; Chen D; Lo HW; Lin HK; Godwin DW; Olivier M; Ghanekar A; Chen K; Miller LD; Gong Y; Capstick M; D'Agostino RB; Munden R; Merle P; Barbault A; Blackstock AW; Bonkovsky HL; Yang GY; Jin G; Liu L; Zhang W; Watabe K; Blackman CF; Pasche BC
EBioMedicine; 2019 Jun; 44():209-224. PubMed ID: 31160272
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels.
Buckner CA; Buckner AL; Koren SA; Persinger MA; Lafrenie RM
PLoS One; 2015; 10(4):e0124136. PubMed ID: 25875081
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
[TBL] [Abstract][Full Text] [Related]
5. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.
Khaitan D; Sankpal UT; Weksler B; Meister EA; Romero IA; Couraud PO; Ningaraj NS
BMC Cancer; 2009 Jul; 9():258. PubMed ID: 19640305
[TBL] [Abstract][Full Text] [Related]
6. T-Type voltage gated calcium channels: a target in breast cancer?
Bhargava A; Saha S
Breast Cancer Res Treat; 2019 Jan; 173(1):11-21. PubMed ID: 30242580
[TBL] [Abstract][Full Text] [Related]
7. Targeting Brain-Adaptive Cancer Stem Cells Prohibits Brain Metastatic Colonization of Triple-Negative Breast Cancer.
Ren D; Zhu X; Kong R; Zhao Z; Sheng J; Wang J; Xu X; Liu J; Cui K; Zhang XH; Zhao H; Wong STC
Cancer Res; 2018 Apr; 78(8):2052-2064. PubMed ID: 29567857
[TBL] [Abstract][Full Text] [Related]
8. Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.
Kanwar N; Carmine-Simmen K; Nair R; Wang C; Moghadas-Jafari S; Blaser H; Tran-Thanh D; Wang D; Wang P; Wang J; Pasculescu A; Datti A; Mak T; Lewis JD; Done SJ
EBioMedicine; 2020 Feb; 52():102646. PubMed ID: 32062352
[TBL] [Abstract][Full Text] [Related]
9. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain.
Xing F; Kobayashi A; Okuda H; Watabe M; Pai SK; Pandey PR; Hirota S; Wilber A; Mo YY; Moore BE; Liu W; Fukuda K; Iiizumi M; Sharma S; Liu Y; Wu K; Peralta E; Watabe K
EMBO Mol Med; 2013 Mar; 5(3):384-96. PubMed ID: 23495140
[TBL] [Abstract][Full Text] [Related]
10. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
[TBL] [Abstract][Full Text] [Related]
11. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
Ippen FM; Grosch JK; Subramanian M; Kuter BM; Liederer BM; Plise EG; Mora JL; Nayyar N; Schmidt SP; Giobbie-Hurder A; Martinez-Lage M; Carter SL; Cahill DP; Wakimoto H; Brastianos PK
Neuro Oncol; 2019 Nov; 21(11):1401-1411. PubMed ID: 31173106
[TBL] [Abstract][Full Text] [Related]
12. The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.
Zhao H; Cui K; Nie F; Wang L; Brandl MB; Jin G; Li F; Mao Y; Xue Z; Rodriguez A; Chang J; Wong ST
Breast Cancer Res Treat; 2012 Jan; 131(2):425-36. PubMed ID: 21394501
[TBL] [Abstract][Full Text] [Related]
13. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Contreras-Zárate MJ; Ormond DR; Gillen AE; Hanna C; Day NL; Serkova NJ; Jacobsen BM; Edgerton SM; Thor AD; Borges VF; Lillehei KO; Graner MW; Kabos P; Cittelly DM
Front Oncol; 2017; 7():252. PubMed ID: 29164052
[TBL] [Abstract][Full Text] [Related]
14. Exosomal Annexin II Promotes Angiogenesis and Breast Cancer Metastasis.
Maji S; Chaudhary P; Akopova I; Nguyen PM; Hare RJ; Gryczynski I; Vishwanatha JK
Mol Cancer Res; 2017 Jan; 15(1):93-105. PubMed ID: 27760843
[TBL] [Abstract][Full Text] [Related]
15. DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.
Woditschka S; Evans L; Duchnowska R; Reed LT; Palmieri D; Qian Y; Badve S; Sledge G; Gril B; Aladjem MI; Fu H; Flores NM; Gökmen-Polar Y; Biernat W; Szutowicz-Zielińska E; Mandat T; Trojanowski T; Och W; Czartoryska-Arlukowicz B; Jassem J; Mitchell JB; Steeg PS
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24948741
[TBL] [Abstract][Full Text] [Related]
16. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
17. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status.
Stark AM; Schem C; Maass N; Hugo HH; Jonat W; Mehdorn HM; Held-Feindt J
Neurol Res; 2010 Apr; 32(3):303-8. PubMed ID: 19909580
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
[TBL] [Abstract][Full Text] [Related]
19. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
20. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
